Position in LRMR
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$3,593,078
+$2,345,327 QoQ
Shares Held
798,462
+143.8% QoQ
Ownership
0.769%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 88%
Shared 8%
None 4%
Common Shares in LRMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. LRMR ranks #105 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in LRMR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,593,078 | 798,462 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,247,751 | 327,494 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $181,710 | 56,257 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $90,613 | 31,354 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $156,193 | 72,649 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $314,048 | 81,150 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $700,213 | 106,903 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,056,490 | 145,723 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,333,895 | 175,744 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $888,104 | 195,188 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $885,691 | 224,226 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $998,184 | 318,909 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $749,450 | 165,442 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $265,007 | 64,167 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $93,478 | 29,212 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $48,485 | 24,738 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $113,958 | 28,138 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $303,609 | 28,138 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $177,642 | 15,407 | Shares | Defined | 2021-11-12 | |
| 2021-03-31 | $202,231 | 13,842 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||